|Bid||0.00 x 1000|
|Ask||53.21 x 800|
|Day's Range||37.03 - 38.22|
|52 Week Range||16.01 - 39.31|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Sep. 09, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||36.75|
Phreesia, the nation’s leading patient intake platform, is pleased to announce that Kristin Roberts, the company’s Vice President of Market Development, has been named to The Software Report’s list of the Top 50 Women Leaders in SaaS of 2020.
Phreesia, Inc. ("Phreesia" or the "Company") (NYSE: PHR), a leading patient intake management platform, announced today the closing of the underwritten public offering of 5,750,000 shares of its common stock (the "Offering"), all of which were sold by the Company, which includes the full exercise of the underwriters’ option to purchase 750,000 additional shares of common stock. The shares were sold at a public offering price of $32.00 per share and were purchased by the underwriters from the Company at the public offering price, less the underwriting discount.
Investors are confident about the company's prospects after its strong secondary stock offering pricing.